Pulike Biological Engineering, Inc. (SHSE: 603566)
Health Care · Pharmaceuticals · CN
CN¥10.29
-0.68% today · -33.1% 1Y
Pulike Biological Engineering, Inc. (SHSE: 603566) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $523.38M and employs 1,519 people.
Over the last twelve months the share price has lost 33.1%, trading between 9.56 and 15.79.
Tweenvest scores Pulike Biological Engineering, Inc. across four factors: quality 74/100, value 70/100, growth 42/100, dividend 69/100. Its strongest factor is quality.
603566 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $523.38M
- Revenue (TTM)
- $153.75M
- P/E
- 20.53
- EPS
- 0.50
- Dividend yield
- 5.83%
- Beta (5Y)
- 0.30
- 52-week high
- CN¥15.79
- 52-week low
- CN¥9.56
- Avg volume (3M)
- —
- Shares outstanding
- 341.92M
- Employees
- 1,519
- Next earnings
- —
About Pulike Biological Engineering, Inc.
Pulike Biological Engineering, Inc. focuses on the entire lifecycle of animal health products, from scientific innovation and manufacturing to market distribution. The company provides a range of veterinary biologicals and pharmaceuticals, including specialized vaccines, antibodies, and medications developed for swine and poultry. Additionally, it produces various disinfectants. Its corporate headquarters are located in Luoyang, China.
- ISIN
- CNE1000025N0
- Founded
- 1995
- Listed since
- May 18, 2015
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.